Katherine Rielly-Gauvin sold $4.1M of Liquidia (LQDA)

Executed Aug 19, disclosed Aug 21, 2 days later.

Value, as filed

$4.1M

55,182 sh across 2 lots

Executed

Aug 19

the trade date, as filed

Disclosed

Aug 21

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KG Katherine Rielly-Gauvin Director profile →

Katherine Rielly-Gauvin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Liquidia Corporation (LQDA). The largest single filing was $4.1M of LQDA (55,182 sh across 2 lots, as filed), executed Aug 19.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→